First Faculty of Medicine, Charles University in Prague Charles University in Prague

We Are Here To Help You

Do you need help or information and you don’t know who to turn to?

Contact us!

XIMBIO - Your Global Reagents Partner - Copy

  • World’s largest non-profit organisation dedicated to commercial use of life science laboratory research tools, reagents, and materials 
  • Wholly owned subsidiary of Cancer Research UK 
  • Partnerships with more than 150 Technology Transfer Offices, over 2000 researchers and more than 200 life science companiesworldwide


Partnership with Charles University 

  • Sale of compounds and other research tools developed at CUNI through Ximbio’s portfolio ( 
  • Ximbio pays CUNI 60 % of revenue generated by offered compounds
    • Researchers are entitled to up to 55 % of the received sum based on Rector’s Directive No. 46/2018 
  • Requires minimum effort on researcher’s side 
    • Preparation of compounds in required commercial amounts takes place in Ximbio’s labs based on provided preparation protocols
  • Opportunity to repurpose compounds and tools developed in research projects and with no further use 
    • Interest in compounds and tools both with and without IP protection


Ximbio’s Portfolio
  • Monoclonal Antibodies 
  • Polyclonal Antibodies
  • Cell Lines
  • Mouse Models
  • Small Molecules
  • Vectors
  • Peptides and Proteins
  • Zebrafish
  • Recombinant Antibodies
  • Lab Consumables
  • Bacteria

What Is Required to Provide?
  • Structure or any other form of characterisation of offered research tools
  • Preparation protocols
  • Optional: 
    • Small samples for analyses
    • Can be crude (Ximbio will purify them themselves)
    • Data from analyses, biological testing, etc.
    • Information on original intended use and other potential applications
    • Information on expected biological activity
    • Other available relevant documentation


Dr. Antonín Králík
Analyst and Patent Specialist
Phone: +420 771 134 090



Page ranking: manage